"Genome-wide association studies, individual genome sequencing, and methods to evaluate proteomes, metabolomes and cellular pathways have identified molecular pathologic mechanisms in neurodegenerative disorders, multiple sclerosis, stroke, epilepsy, and other neurological disorders." . . . . .